Euclid Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-246,232
Closed -$19M 214
2016
Q2
$19M Sell
246,232
-33,150
-12% -$2.62M 0.82% 19
2016
Q1
$21.8M Sell
279,382
-70,963
-20% -$4.96M 0.83% 25
2015
Q4
$23.7M Sell
350,345
-165,965
-32% -$11.6M 0.72% 29
2015
Q3
$39.9M Sell
516,310
-105,800
-17% -$9.37M 1.81% 10
2015
Q2
$56.4M Buy
622,110
+357,570
+135% +$28.6M 1.11% 11
2015
Q1
$19.9M Buy
264,540
+103,540
+64% +$7.44M 0.37% 61
2014
Q4
$11.8M Buy
161,000
+118,000
+274% +$8.29M 0.11% 180
2014
Q3
$3.03M Buy
+43,000
New +$2.84M 0.02% 449

Other funds holding HCA

Euclid Advisors's HCA Position: Q3 2016 in Review

Euclid Advisors sold out of HCA Healthcare (HCA) in Q3 2016, closing a stake of 246,232 shares — an estimated $19M sold.

Euclid Advisors first reported a position in HCA in Q3 2014 and held it in 8 quarters. The position peaked at $56.4M in Q2 2015. 587 funds tracked by Wall St. Rank hold HCA as of Q3 2016.

  • Euclid Advisors reported no remaining HCA Healthcare position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 246,232 HCA Healthcare shares in Q3 2016, an estimated $19M.
  • Euclid Advisors first reported a position in HCA Healthcare in Q3 2014 and held it in 8 quarters.
  • Euclid Advisors's HCA Healthcare position peaked at $56.4M in Q2 2015.
  • 587 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.